PUBLISHER: The Business Research Company | PRODUCT CODE: 1961661
PUBLISHER: The Business Research Company | PRODUCT CODE: 1961661
A pharmacy is a facility where individuals can acquire prescription medications, and it might be situated within a grocery store, drugstore, chemist, or other establishments. A drug store is an establishment primarily engaged in the sale of pharmaceuticals, medicines, and pharmaceutical preparations. These stores typically have a dedicated prescription department and employ a registered pharmacist available at all times.
Pharmacies and drug stores primarily deal with two main types of drugs prescription drugs and over-the-counter drugs. Prescription drugs are medications that can only be obtained with a prescription from a physician. Various types of pharmacies include community pharmacy, hospital pharmacy, clinical pharmacy, industrial pharmacy, compounding pharmacy, consulting pharmacy, ambulatory care pharmacy, regulatory pharmacy, and homecare pharmacy. Different product types available at these establishments include skincare products, cold and flu remedies, dental products, weight loss aids, vitamins, and various other product types.
Tariffs have influenced the pharmacies and drug stores market by increasing the cost of imported pharmaceuticals, medical equipment, and raw materials for drug manufacturing. Prescription drugs and OTC products have been particularly affected in regions heavily reliant on imports, such as North America and Europe. Community and hospital pharmacy segments face higher operational costs due to these tariffs. On the positive side, tariffs are encouraging local production and sourcing, creating opportunities for domestic manufacturers to expand and innovate.
The pharmacies and drug stores market research report is one of a series of new reports from The Business Research Company that provides pharmacies and drug stores market statistics, including pharmacies and drug stores industry global market size, regional shares, competitors with a pharmacies and drug stores market share, detailed pharmacies and drug stores market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacies and drug stores industry. This pharmacies and drug stores market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmacies and drug stores market size has grown strongly in recent years. It will grow from $1222.15 billion in 2025 to $1293.11 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing prescription drug usage, growth of brick-and-mortar pharmacies, rise in chronic disease prevalence, limited digital healthcare adoption, government-led health initiatives.
The pharmacies and drug stores market size is expected to see strong growth in the next few years. It will grow to $1654.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing e-pharmacy adoption, integration of ai and iot in pharmacy operations, increasing demand for personalized medicine, expansion of home care pharmacy services, rising health awareness and preventive care. Major trends in the forecast period include expansion of community pharmacies, rise in otc product demand, growth of clinical and ambulatory care pharmacy services, increase in compounding and home care pharmacies, focus on patient counseling and consulting services.
The rising prevalence of chronic illnesses is anticipated to drive the expansion of the pharmacies and drugstore market in the coming years. A chronic illness is a health condition that lasts for an extended period, generally three months or longer, and often remains throughout an individual's lifetime. Pharmacies and drugstores support the management of chronic illnesses by providing necessary medications and delivering patient guidance. They function as easily accessible points of care, promoting regular medication adherence and offering health-related advice for long-term condition management. For example, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of adults in the United States, representing approximately 194 million people, reported having at least one chronic condition in 2023, with prevalence levels of 59.5% among young adults, 78.4% among middle-aged adults, and 93.0% among older adults. As a result, the growing incidence of chronic diseases is contributing to the growth of the pharmacies and drugstore market.
Major companies operating in the pharmacies and drug stores market are focusing on adopting AI-driven pharmacy automation solutions, such as AI-powered pharmacy dispensing platforms, to improve operational efficiency, accuracy, and clinical decision-making. AI-powered pharmacy dispensing platforms are software systems that utilize artificial intelligence and automation to manage prescription dispensing workflows, optimize inventory, and assist pharmacists with data-driven insights, enabling functions such as real-time prescription processing, workflow optimization, and decision support. For instance, in October 2024, Alto Pharmacy, a US-based full-service digital pharmacy providing seamless pharmacy experiences through innovative technology, launched Alto Technologies, offering a suite of pharmacy solutions designed to enhance medication management efficiency and accessibility. The Alto Complete(TM) platform integrates hub and dispensing services, using automation and artificial intelligence to streamline operations. It delivers faster prescription processing, cost efficiency, and an improved patient experience. The platform also provides real-time data insights, benefiting various stakeholders in the healthcare ecosystem. Alto Technologies provides customizable solutions for partners, enabling healthcare providers to enhance services while maintaining patient care. The objective is to transform the pharmacy landscape.
In October 2025, CVS Pharmacy, a US-based retail pharmacy company, acquired Rite Aid assets for an undisclosed amount. With this acquisition, CVS Pharmacy seeks to enhance access to convenient pharmacy care across the United States and reinforce its presence within local communities. Rite Aid is a US-based retail pharmacy and drugstore chain that offers prescriptions, health and beauty products, general merchandise, and pharmacy benefit management (PBM) services.
Major companies operating in the pharmacies and drug stores market are CVS Health Corporation, Walgreens Boots Alliance Inc., Alliance Boots GmbH & Co. KG, Rite Aid Corporation, AS Watson Group, Shoppers Drug Mart Corporation, Matsumotokiyoshi Holdings Co. Ltd., MedPlus Health Services Inc., Diplomat Pharmacy Inc., Rexall Sundown Inc., PharMerica Corporation, Kinney Drugs Inc., Bartell Drugs Inc., China Nepstar Holding Company Limited, Progressive Care Inc., Lewis Drug Stores Inc., Grupo Casa Saba Sab De Cv, Omnicare Inc., Dougherty's Pharmacy Inc., Medicap Pharma, Apollo Pharmacy Limited, Discount Drug Stores Inc., Good Neighbor Pharmacy, Fred's Pharmacy Inc., Navarro Discount Pharmacies LLC, Discount Drug Mart Inc., Kerr Drug Inc.
Asia-Pacific was the largest region in the pharmacies and drug stores market in 2025. North America was the second-largest region in the global pharmacies and drug stores market share. The regions covered in the pharmacies and drug stores market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pharmacies and drug stores market report are Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
The pharmacies and drug stores market includes revenues earned by entities by branded prescription drugs, generic drugs, non-prescription medicines, personal health supplies, and dietary supplements, cosmetics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmacies and Drug Stores Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmacies and drug stores market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmacies and drug stores ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmacies and drug stores market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.